Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Simon Mendelsohn (cohort 2015-2016) co-authored this publications reporting the findings of a study that found a host blood test that can find those at high risk of tuberculosis in people living with HIV.

Researchers from the South African Tuberculosis Vaccine Initiative at the University of Cape Town, the Aurum Institute, the Centre for the AIDS Programme of Research in South Africa, Stellenbosch University, the London School of Hygiene and Tropical Medicine and the Fred Hutchinson Cancer Research Center have published the results from a study of a blood-based RNA biomarker which tested diagnostic and prognostic performance for tuberculosis (TB) in people living with HIV in The Lancet Global Health journal.

This publication advances the development of a point-of care blood test with which health practitioners could accurately identify people at risk of TB disease, who would then require confirmatory diagnostic testing and treatment, or others who are likely to progress from M. tuberculosis infection to active TB disease and make it possible to apply available TB preventive antibiotic regimens selectively to those who are most likely to benefit in communities.

 

Visit the the Lancet Global Health to read the full study.

Visit Satvi website to read the media release.

Similar stories

Delays in presentation of intussusception and development of gangrene in Zimbabwe

Student Dennis Mazingi (cohort 2020-2021) co-authored this paper focused on the importance of a prompt diagnosis and treatment of intussusception in Zimbabwe. Their findings highlight the need to improve early diagnosis of intussusception and prompt referral of patients for treatment.

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

Sandra Adele (cohort 2020-2021) co-authored this paper on the efficacy of the Oxford Astra-Zeneca vaccine for the 40 million people globally living with HIV. This study aimed to assess the vaccine’s ability to stimulate an immune response on those who have their immunity compromised.

Alumna Parinda Wattanasri (cohort 2019-2020) talks about vaccine passports in Thailand Today

Alumna Parinda Wattanasri (cohort 2019-2020) was interviewed by Thailand Today on vaccine passports. and how they may become a sustainable plan to reopening Thailand.

The health policy response to COVID-19 in Malawi

Grace Mzumara (cohort 2019-2020) co-authored this paper analysing the health public response to the COVID pandemic and identifying gaps in the response in need of improvement.

Students win a £10K prise on the All-Innovate Ideas Competition

Dennis Mazingi and Tafadzwa Matika (cohort 2020-2021) won the overall best pitch and the grand prize of £10,000 on the All-Innovate Ideas Competition for their idea of a fast delivery service in Zimbabue that would accelerate the country's step into online commerce.

Addressing emerging global health security threats in Sub-Saharan Africa: Time for a regional health agenda?

Epie Terrence Beteck (cohort 2019-2020) wrote this article on the state of play of health care in Sub-Saharan Africa and what should be done to improve healthcare systems and strengthen outbreak response.